All Stories

  1. The Edges of Elimination: Barriers to Malaria Elimination in Tribal and Island Communities of India
  2. Phenotypic plasticity as a function of genetic polymorphism: thermal dominance reversal in Drosophila species with contrasting melanism
  3. Phenotypic plasticity as a function of genetic polymorphism: thermal dominance reversal in Drosophila species with contrasting melanism
  4. Evolutionary Genetic Analysis of the Pyrazinamidase Gene in Seven Global Populations of Mycobacterium tuberculosis
  5. Therapeutic efficacy of artemether–lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markers
  6. Plasmodium falciparum histidine-rich protein 2/3 gene deletions and repeat motifs in Chhattisgarh, India (2017–2018)
  7. Author Correction: Genome resequencing and genome-wide polymorphisms in mosquito vectors Aedes aegypti and Aedes albopictus from south India
  8. Evolution of tandem repeats in putative circumsporozoite protein to enhance its function: A recent and exclusive event in Plasmodium vivax in India
  9. Low prevalence of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions in malaria-endemic states of India
  10. Genetic analysis of the circumsporozoite gene in Plasmodium falciparum isolates from Cameroon: Implications for efficacy and deployment of RTS,S/AS01 vaccine
  11. Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India
  12. Genome resequencing and genome-wide polymorphisms in mosquito vectors Aedes aegypti and Aedes albopictus from south India
  13. Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India
  14. Crimean-Congo hemorrhagic fever virus prevalence in livestock of Jabalpur, Madhya Pradesh, Central India and its implications for public health
  15. Dengue control, if not by vaccination and vector strategies, then possibly by therapeutics
  16. Genetic diversity and natural selection of apical membrane antigen-1 (ama-1) in Cameroonian Plasmodium falciparum isolates
  17. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India
  18. Low Prevalence of Antimalarial Resistance Mutations in India During 2014–2015: Impact of Combining First-line Therapy With Primaquine
  19. Determinants of tuberculosis: an example of high tuberculosis burden in the Saharia tribe
  20. Characterisation of Anopheles species composition and genetic diversity in Meghalaya, northeast India, using molecular identification tools
  21. How can the complex epidemiology of malaria in India impact its elimination?
  22. Controlling sickle cell disease: The need of the hour
  23. Letter:A Pilot Health and Nutritional Assessment of Tribes Living in a High Altitude District of Himachal Pradesh, India
  24. A comparative assessment of the community frontline health workers for their knowledge and practices of malaria diagnosis and treatment in three contiguous districts Mandla, Balaghat, and Dindori of Madhya Pradesh, India
  25. Evaluation of the model malaria elimination strategy in Mandla district along with its neighbouring districts: a time series analysis from 2008 to 2020
  26. Mass screening and treatment (MSaT) for identifying and treating asymptomatic cases of malaria-malaria elimination demonstration project (MEDP), Mandla, Madhya Pradesh
  27. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India
  28. A qualitative study on community perceptions on quality of healthcare services they received in the Malaria Elimination Demonstration Project in district Mandla, India
  29. Significance of nested PCR testing for the detection of low-density malaria infection amongst febrile patients from the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh, India
  30. The Impact, Emerging Needs, and New Research Questions Arising from 12 Years of the Center for the Study of Complex Malaria in India
  31. Profile of diseases prevalent in Datia District of Madhya Pradesh, India
  32. First Report on Intensity Bioassays for Pyrethroid Resistance in Anopheles culicifacies s.l in District Dindori of Madhya Pradesh State and Districts Kanker and Bastar of Chhattisgarh State, India
  33. Sickle cell disease in India: Prevention-driven social and public health implications
  34. Decline of Japanese encephalitis in Eastern Uttar Pradesh, India, 2009-2019
  35. Molecular epidemiology of Orientia tsutsugamushi from outbreak regions, Madhya Pradesh, central India
  36. Time for Isoniazid Pharmacogenomic-Guided Therapy of Tuberculosis Based on NAT2 Acetylation Profiles in India
  37. Unreported mixed Plasmodium species infection may increase vivax malaria in India: a challenge for malaria elimination
  38. Monitoring of the Village Malaria Workers to conduct activities of Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
  39. Monitoring of Insecticide Resistance in Anopheles culicifacies in Twelve Districts of Madhya Pradesh, Central India (2017–2019)
  40. Asymptomatic low-density Plasmodium falciparum infections: A challenge in malaria elimination in India
  41. Evaluation of Microchip-Based Point-Of-Care Device “Gazelle” for Diagnosis of Sickle Cell Disease in India
  42. Learnings from two independent malaria elimination demonstration projects in India
  43. Assessing community knowledge, attitude and practices to strengthen communication strategy for Malaria Elimination Demonstration Project in Mandla
  44. Withdrawal Notice: Community-wide Screening of Symptomatic and Asymptomatic Infection of Mycobacterium tuberculosis in the Saharia tribe of India
  45. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
  46. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India
  47. An integrated virtual screening and drug repurposing strategy for the discovery of new antimalarial drugs against Plasmodium falciparum phosphatidylinositol 3‐kinase
  48. The Potential of mHealth as a Game Changer for the Management of Sickle Cell Disease in India
  49. Digitisation and realtime sharing of unified surveillance tool and clinicopathological data for efficient management of disease outbreaks
  50. Comparison of polymerase chain reaction, microscopy, and rapid diagnostic test in malaria detection in a high burden state (Odisha) of India
  51. Improvement of Indoor Residual Spraying and Long‐Lasting Insecticidal Net services through structured monitoring and supervision as part of the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
  52. A model for malaria elimination based on learnings from the Malaria Elimination Demonstration Project, Mandla district, Madhya Pradesh
  53. Assessment of ASHA for knowledge, diagnosis and treatment on malaria in Mandla district of Madhya Pradesh as part of the malaria elimination demonstration project
  54. Spatial and temporal village-level prevalence of Plasmodium infection and associated risk factors in two districts of Meghalaya, India
  55. Significance of training, monitoring and assessment of malaria workers in achieving malaria elimination goal of Malaria Elimination Demonstration Project
  56. Socio-economic determinants of malaria in tribal dominated Mandla district enrolled in Malaria Elimination Demonstration Project in Madhya Pradesh
  57. Determination of cut-off of diagnostic ELISA for Scrub typhus in endemic setup
  58. Aiming for a tuberculosis-free India: Perspective of a highly endemic Particularly Vulnerable Tribal Group (PVTG)
  59. A study of malaria vector surveillance as part of the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
  60. Study design and operational framework for a community-based Malaria Elimination Demonstration Project (MEDP) in 1233 villages of district Mandla, Madhya Pradesh
  61. Gandhi's vision and the current health crisis: an Indian perspective
  62. Demonstration of indigenous malaria elimination through Track-Test-Treat-Track (T4) strategy in a Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh
  63. CRISPR-Cas9 system: A genome-editing tool with endless possibilities
  64. Prevalence of SARS-CoV-2 infection in India
  65. Presence of additional Plasmodium vivax malaria in Duffy negative individuals from Southwestern Nigeria
  66. Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?
  67. First successful field evaluation of new, one-minute haemozoin-based malaria diagnostic device
  68. Paper-based microchip electrophoresis for point-of-care hemoglobin testing
  69. Vector-borne diseases: Mosquito holobiont and novel methods for vector control
  70. Sequence Analysis of the K13‐Propeller Gene in Artemisinin Challenging Plasmodium falciparum Isolates from Malaria Endemic Areas of Odisha, India: A Molecular Surveillance Study
  71. Insecticide resistance in Indian Anopheles: A stumbling block for malaria elimination
  72. International Multi-Site Clinical Validation of Point-of-Care Microchip Electrophoresis Test for Hemoglobin Variant Identification
  73. Evolutionary interplay of single nucleotide polymorphisms at the promoter region of TNF-α gene in different clinical outcomes of malaria in India
  74. MERA India: Malaria Elimination Research Alliance India
  75. ICMR research initiatives enabling malaria elimination in India
  76. Malaria elimination: Using past and present experience to make malaria-free India by 2030
  77. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria
  78. Status of Artemisinin Resistance in Malaria Parasite Plasmodium falciparum from Molecular Analyses of the Kelch13 Gene in Southwestern Nigeria
  79. HRP-2 deletion: a hole in the ship of malaria elimination
  80. Plasmodium falciparumMSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection
  81. Malaria diagnosis by PCR revealed differential distribution of mono and mixed species infections by Plasmodium falciparum and P. vivax in India
  82. A Proteogenomic Analysis of Haptoglobin in Malaria
  83. Can Mixed Parasite Infections Thwart Targeted Malaria Elimination Program in India?
  84. Analysis of genetic diversity in the chloroquine-resistant gene Pfcrt in field Plasmodium falciparum isolates from five regions of the southern Cameroon
  85. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India
  86. An additional observation of Plasmodium vivax malaria infection in Duffy-negative individuals from Cameroon
  87. An epidemiological study of dengue in Delhi, India
  88. Genotyping malaria parasites with DNA barcodes
  89. Mitochondrial population genomic analyses reveal population structure and demography of Indian Plasmodium falciparum
  90. The distinctive features of Indian malaria parasites
  91. Multilocus nuclear DNA markers reveal population structure and demography ofAnopheles minimus
  92. Genetic Polymorphisms in VIR Genes among Indian Plasmodium vivax Populations
  93. Molecular Evidence of Plasmodium vivax Mono and Mixed Malaria Parasite Infections in Duffy-Negative Native Cameroonians
  94. DNA sequence polymorphisms of the pfmdr1 gene and association of mutations with the pfcrt gene in Indian Plasmodium falciparum isolates
  95. Molecular population genetics of the NADPH cytochrome P450 reductase (CPR) gene in Anopheles minimus
  96. Does malaria epidemiology project Cameroon as ‘Africa in miniature’?
  97. Mitochondrial genome sequence diversity of Indian Plasmodium falciparum isolates
  98. New insights into the evolutionary history ofPlasmodium falciparumfrom mitochondrial genome sequence analyses of Indian isolates
  99. Whole Mitochondrial Genome Sequence of an Indian Plasmodium falciparum Field Isolate
  100. Genetics of chloroquine-resistant malaria: a haplotypic view
  101. Analyses of genetic variations at microsatellite loci present in-and-around the Pfcrt gene in Indian Plasmodium falciparum
  102. Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum
  103. NAT2sequence polymorphisms and acetylation profiles in Indians
  104. Genomics, Population Genetics and Evolutionary History of Plasmodium vivax
  105. Assessing the genetic diversity of the vir genes in Indian Plasmodium vivax population
  106. Natural Selection Mediated Association of the Duffy (FY) Gene Polymorphisms with Plasmodium vivax Malaria in India
  107. Development of multilocus putatively neutral DNA markers in the X-chromosome for population genetic studies in humans
  108. Malaria in India: The Center for the Study of Complex Malaria in India
  109. Inferring the evolutionary history of IndianPlasmodium vivaxfrom population genetic analyses of multilocus nuclear DNA fragments
  110. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum
  111. Characterization, comparative genomics, and evolutionary inferences of a human drug metabolizing (NAT2) gene
  112. Population genetic analyses of Plasmodium falciparum chloroquine receptor transporter gene haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India
  113. Multilocus nuclear DNA markers and genetic parameters in an Indian Anopheles minimus population
  114. Sequence analysis of coding DNA fragments of pfcrt and pfmdr-1 genes in Plasmodium falciparum isolates from Odisha, India
  115. Comparative genomic analysis of simple sequence repeats in three Plasmodium species
  116. Phylogenetic inference of Indian malaria vectors from multilocus DNA sequences
  117. Evolutionary insights into insecticide resistance gene families of Anopheles gambiae
  118. Single nucleotide polymorphisms, putatively neutral DNA markers and population genetic parameters in Indian Plasmodium vivax isolates
  119. Malaria parasite genome scan: insights into antimalarial resistance
  120. High proportion of mixed-speciesPlasmodiuminfections in India revealed by PCR diagnostic assay
  121. Evolutionary genetic insights into Plasmodium falciparum functional genes
  122. Why is it important to study malaria epidemiology in India?
  123. Plasmodium falciparum and Plasmodium vivax: so similar, yet very different
  124. Abdominal pigmentation in Drosophila melanogaster females from natural Indian populations
  125. Abdominal pigmentation in Drosophila melanogaster females from natural Indian populations
  126. Fine-scale evolutionary genetic insights into Anopheles gambiae X-chromosome
  127. Genetic characterization and evolutionary inference of TNF-α through computational analysis
  128. Evolution of mating isolation between populations ofDrosophila ananassae
  129. Fine-scale genetic characterization of Plasmodium falciparum chromosome 7 encompassing the antigenic var and the drug-resistant pfcrt genes
  130. Evolutionary paradigm of chloroquine-resistant malaria in India
  131. Development of nuclear DNA markers for evolutionary studies in Plasmodium falciparum
  132. Homogeneity of common cosmopolitan inversion frequencies in Southeast AsianDrosophila melanogaster
  133. The Role of Natural Selection in Genetic Differentiation of Worldwide Populations of Drosophila ananassae
  134. Inferring the Population Structure and Demography of Drosophila ananassae From Multilocus Data
  135. Inversion polymorphism and extra bristles in Indian natural populations of Drosophila ananassae: joint variation
  136. Abdominal pigmentation and growth temperature in Indian Drosophila melanogaster: Evidence for genotype-environment interaction
  137. Changes of inversion polymorphism in laboratory populations of Drosophila melanogaster
  138. Genetic differentiation and inversion clines in Indian natural populations of Drosophila melanogaster
  139. DNA finger-printing in India
  140. Inversion polymorphism in Indian natural populations of Drosophila melonogaster